SUMMER KELLER: Open Payments
NPI 1417411828 · NORTH KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $343 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $153 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $93 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Dexcom G6 Transmitter, AIRSUPRA, MOUNJARO, FARXIGA, Ozempic.
Industry payments across MO — which companies pay providers there.
